These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28181816)

  • 21. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.
    Ren X; Liu H; Zhang M; Wang M; Ma S
    Mol Med Rep; 2016 Sep; 14(3):2431-8. PubMed ID: 27484725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells.
    Schumacher G; Bruckheimer EM; Beham AW; Honda T; Brisbay S; Roth JA; Logothetis C; McDonnell TJ
    Int J Cancer; 2001 Jan; 91(2):159-66. PubMed ID: 11146439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.
    Xande JG; Dias AP; Tamura RE; Cruz MC; Brito B; Ferreira RA; Strauss BE; Costanzi-Strauss E
    Gene Ther; 2020 Feb; 27(1-2):51-61. PubMed ID: 31439890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential involvement of the Fas receptor/ligand system in p53-dependent apoptosis in human prostate cancer cells.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    Prostate; 2000 Dec; 45(4):341-9. PubMed ID: 11102960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer.
    Nande R; Greco A; Gossman MS; Lopez JP; Claudio L; Salvatore M; Brunetti A; Denvir J; Howard CM; Claudio PP
    Curr Gene Ther; 2013 Jun; 13(3):163-74. PubMed ID: 23531191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving adenoviral vectors and strategies for prostate cancer gene therapy.
    Tamura RE; de Luna IV; Lana MG; Strauss BE
    Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e476s. PubMed ID: 30133562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
    Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.
    Magnusson MK; Kraaij R; Leadley RM; De Ridder CM; van Weerden WM; Van Schie KA; Van der Kroeg M; Hoeben RC; Maitland NJ; Lindholm L
    Hum Gene Ther; 2012 Jan; 23(1):70-82. PubMed ID: 21875358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
    Xu M; Xie Y; Sheng W; Miao J; Yang J
    Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines.
    Pataer A; Smythe WR; Yu R; Fang B; McDonnell T; Roth JA; Swisher SG
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):61-7. PubMed ID: 11135160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy.
    Jacobberger JW; Sramkoski RM; Zhang D; Zumstein LA; Doerksen LD; Merritt JA; Wright SA; Shults KE
    Cytometry; 1999 Oct; 38(5):201-13. PubMed ID: 10516606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA; Davidson BL; Graham SM; Kern JA
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an adenoviral vector with robust expression driven by p53.
    Bajgelman MC; Strauss BE
    Virology; 2008 Feb; 371(1):8-13. PubMed ID: 18076963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.